chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the second day of the vaccine 1/24/2021 I had a little bit of chills & body aches. This symptoms lasted for 48hrs.
Patient developed angioedema and rash around 8 am on 2/26/21. Rash was macular and erythematous located on the arms, torso, and legs. Angioedema involved the tongue. Patient presented to the emergency department and received epinephrine, Benadryl, methylprednisolone, and famotidine. She was admitted to the hospital overnight for observation.
I started experiencing violent night mares six weeks after the vaccination, blood oxygen 87 dropping  and awake in a panic state,  extreme hair losss 12/21/2021 - 01/2022/2022 six weeks after. I went to the doctor   02/08/2022 , tested thyriod, ekg, and scheduled heart test- stress, ultra sound of renial artieries and heart. back off vivid night mares 03/01/2022.  Upcoming appointment for heart results.  Improving but not recovered yet.
Ag test Feb2022 was exposed to someone at 1/17 event/test result:positive; Ag test Feb2022 was exposed to someone at 1/17 event/test result:positive/Dry and nasal congestion; Ag test Feb2022 was exposed to someone at 1/17 event/test result:positive; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from product quality group.  A 37 year-old male patient received bnt162b2 (BNT162B2), administration date 05Nov2021 (Lot number: FF2589) at the age of 37 years as dose 3 (booster), single, administration date 18Feb2021 (Lot number: EL3247) as dose 2, single and administration date 26Jan2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant) with onset 22Feb2022, outcome "unknown", SARS-COV-1 TEST POSITIVE (medically significant) with onset 22Feb2022, outcome "unknown" and all described as "Ag test Feb2022 was exposed to someone at 1/17 event/test result:positive/Dry and nasal congestion"; EXPOSURE TO SARS-COV-2 (non-serious) with onset Feb2022, outcome "unknown", described as "Ag test Feb2022 was exposed to someone at 1/17 event/test result:positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (22Feb2022) positive, notes: Other. It was unknown if therapeutic measures were taken as a result of vaccination failure, sars-cov-1 test positive, exposure to sars-cov-2.  Clinical Course: sx ST dry and nasal congestion mild late Feb2021 and then + Ag test Feb2022 was exposed to someone at 1/17 event. It was unknown if the patient receive any other vaccines within 4 weeks prior to the COVID vaccine  No follow-up attempts are possible. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
This spontaneous report was received from a medical assistant via patient's mother and refers to a male child patient of unknown age. The patient's pertinent medical history, drug reactions and allergies were not reported. Concomitant therapies were not provided. On an unknown date in November 2017, the patient was vaccinated with PROQUAD (albumin status was not provided) lot # N014634 with an expiration date 07-NOV-2018 , subcutaneously for prophylaxis (dose and anatomical location were not reported). Medical assistant reported the patient's mother was not sure if her child received the proper dose of the PROQUAD as there was a wet spot on the paper on the exam table after he received the vaccine. No adverse effects were reported.
Immediately after receiving the shot pain in upper arm then numbness (like hitting the "funny bone") shooting pain down arm to fingertips.  Mentioned to the nurse on-site.  After one month, saw doctor prescribed Neurontin and Elavil for chronic pain.  Advised not to lift over 4 lbs. Follow-up with physician in 2 weeks.
Pain upon injection. Pt. complains of immobility of arm where shot was administered. Can't  lift arm using shoulder for 2 weeks. Able to move side to side. Referred to physician for evaluation. Possibly brachial neuritis.
The nurse did the shot to heard and went up to high on my right arm She hit the bone my shoulder still ant the same my hand keeps going numb I got sick from the shot I had lightheadness, dizzens, heart racing,
Hypotonic, pallor for 4-6hr. No side effect after 12 hr post dose
Aches & pains, head congestion & runny nose; tightness in chest, dry cough; 10 days later asthma attack; vertigo x 4 days w/asthma attack;
Giant sized golf ball hives swollen and enlarged; red and itchy on my throat and neck area in one spot; red and itchy on my throat and neck area in one spot; Giant sized golf ball hives swollen and enlarged; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP). The reporter is the patient.  A 7 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Dec2021 15:00 (Batch/Lot number: unknown) at the age of 7 years as dose1, single for covid-19 immunisation. Relevant medical history included: "ASTHMA" (unspecified if ongoing); "seasonal allergie" (unspecified if ongoing); "dog allergy" (unspecified if ongoing); "bug bites" (unspecified if ongoing); "ADHD" (unspecified if ongoing); "Allergic rhinitis" (unspecified if ongoing); "Chronic otitis media" (unspecified if ongoing); "mild asthama" (unspecified if ongoing), notes: Family history: mild asthma. Family history included: "speech delay" (unspecified if ongoing). Concomitant medication(s) included: GUANFACINE HCL taken for attention deficit hyperactivity disorder (ongoing); ALBUTEROL HFA taken for asthma (ongoing); VENTOLIN HFA taken for asthma (ongoing). The following information was reported: URTICARIA (non-serious), SWELLING (non-serious) all with onset 16Dec2021 15:30, outcome "not recovered" and all described as "Giant sized golf ball hives swollen and enlarged"; ERYTHEMA (non-serious), PRURITUS (non-serious) all with onset 16Dec2021 15:30, outcome "not recovered" and all described as "red and itchy on my throat and neck area in one spot". Therapeutic measures were taken as a result of urticaria, erythema, pruritus, swelling.  Additional information: Adverse event -Giant sized golf ball hives swollen and enlarged and red and itchy on my throat and neck area in one spot 30 minutes after I got the shot hasn't gone away even took Benadryl and used the tropical cream. Patient had covid  prior vaccination. Patient was not covid tested post vaccination. It was unknown whether patient had known allergies. Patient did not had any other vaccinations within four weeks prior to the first administration date of the suspect vaccines.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
never had AFib until receive the 2 shots and booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization; Bnt162b2 (Dose: 2), for COVID-19 Immunization. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "never had AFib until receive the 2 shots and booster". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The first day after I received the vaccine I experienced symptoms in guidance with all available resources. I was fatigued, my arm was sore at the sight of injection. I remember sleeping at least 12 hours.  A few days later I began to experience severe intermittent chest pain. The area under my arm was extremely tender, as were the area behind my left knee. The adverse event as stated in the report was a sudden jolt of searing pain on my left side. It lasted only a few moments and felt like it traveled from my left shoulder down to my left thigh and behind my knee. It nearly knocked me off my feet. I remained with a lingering pain in my leg and upper left back until today.  I reached out the pharmacist  who administered the vaccine about the side effects and she advised me to immediately contact my doctor's office. I visited my doctor's office yesterday (6/3/21) and he assured me I didn't have any blood clots. He advised me to use a heating pad for the pain in my leg. He also said that sometimes the lingering side effects from the vaccine may last weeks in rare cases. Those discomforts are finally starting to subside. I had no treatment outside of elevated levels of hydration, taking Tylenol and resting.
Next day after imm. patient had fever of 103-104, pale, vomiting, weakness, had dx of bladder infection that day. Refuses to take anymore HPV.
COVID-19 positive; This spontaneous case from the United States was retrieved on 29-Aug-2022 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2006126-1), reported by other healthcare professional and concerned a 43-year-old, female patient.  The patient's concurrent conditions included chronic low back pain, restless leg syndrome, depression, cyclical vomiting, gastrooesophageal reflux disease (GERD), penicillin, tramadol, codeine, morphine, tylenol with codeine allergy and lactose intolerance. The patient's concomitant medications included Voltaren gel (diclofenac), fluoxetine, gabapentin, iron, Vyvanse (lisdexamfetamine), Icy Hot patches, pantoprazole and pramipexole, all used for an unreported indication.   On 27-Oct-2021, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine inact split 4v; route of administration: intramuscular (IM), anatomical location: left arm (LA), dose: reported as 'one', and indication: not reported). The batch number reported was P100355694 (reported batch number was identified by Seqirus to be linked to suspect product Afluria Quadrivalent instead of reported suspect product Fluad Quadrivalent).  On the same day, the patient was vaccinated with non-company co-suspect Covid-19 Janssen (COVID-19 vaccine NRVV Ad26 (JNJ 78436735); route of administration: intramuscular (IM), anatomical location: right arm (RA), dose: reported as 'one', and indication: not reported). The batch number reported was 1822811.  On 29-Dec-2021, two months and two days after receiving Afluria Quadrivalent and co-suspect Covid-19 Janssen, the patient had a SARS-CoV-2 RNA NAAT test, and the result was positive.  On an unspecified date, the patient visited the physician's office, but no further information was provided.  The outcome of the event was unknown.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: Two months and two days after receiving Afluria Quadrivalent and co-suspect Covid-19 vaccine, the patient had a SARS-CoV-2 RNA NAAT test, and the result was positive. However, causality is assessed as not related due to biological implausibility.; Sender's Comments: Two months and two days after receiving Afluria Quadrivalent and co-suspect Covid-19 vaccine, the patient had a SARS-CoV-2 RNA NAAT test, and the result was positive. However, causality is assessed as not related due to biological implausibility.
Rash, heat, and swelling at injection site (right deltoid) and around arm, patient was treated by a physician for reaction-physician stated it looked like an allergic reactions and not an injection site reaction.
she had the chills, fever; not feeling good at all; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) right before noon as single dose for covid-19 immunisation. Medical history included emphysema, blood clot issues and breast cancer. Patient also stated that it is that time of years, so thought it would be allergies. Concomitant medications were not reported. On 31Mar2021, after 8 hours of vaccination patient had fever chills and was not feeling good at all and that she expected this. Patient had heard from family members that it still could be from Covid in the body and do not know what to expect. She was confused and would like some help and guidance for "what should she expect" and "what should she do and the family members they have been around". She also clarified that this could be caused by the antibodies from the vaccine and declined to provide any further details for full report. The patient stated that she just wants side effects, want to know what to expect and to prevent the Covid virus. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Received the vaccine and the following day started experiencing aches, chills, nausea and headache. An ERT (emergency response was called at work) ; however, there was no further treatment.
Elevated heart rate from 58 resting heart rate to 72 resting heart rate overnight. Elevated respiratory rate, 16.90 compared to 15 avg overnight, fatigue, within one hour of vaccine, restless, sleep, elevated skin temperature overnight.
Arm and neck pain, loss of motion in left arm numbness of fingers that eventually turned to full numbness of left arm. Pt then had body aches and vomiting for several hours. SOB.
Covid; Covid; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 55 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 55 years as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant), outcome "unknown" and all described as "Covid". The patient had 2 doses of Pfizer Bio N Tech vaccine and developed covid and was subsequently hospitalized.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of serious events drug ineffective and COVID-19 cannot be totally excluded.
On 1/22/05, the patient suffered a witnessed, 45 minute seizure.  At medical center, he was found to have temperature 101.7, in status epilepticus.  He was treated with valium and phenobarbital.  He was intubated and transferred to another medical center.  LP and head CT were negative. Discharge summary states dehydration, thrush, hypoxia. msv Information received from medical records states apnea, vomiting, flushed as symptoms.msv
foggy vision/black and looked smoky.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 54 year-old male patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 06Apr2021 11:00 (Lot number: EP6955) at the age of 54 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Really high eye pressure", start date: 2008 (ongoing). Concomitant medication(s) included: LATANOPROST taken for intracranial pressure increased. Past drug history included: Xalatan. The following information was reported: VISION BLURRED (non-serious) with onset 06Apr2021, outcome "not recovered", described as "foggy vision/black and looked smoky."  Additional information: First dose: foggy vision: The caller received the first dose, could see ahead further in the distance a fog. The caller states in the further distance was kind of black and looked smoky. Caller clarifies this occurred after receiving the first dose Adult Pfizer Covid 19 Vaccine. The caller states caller's vision got foggy. The caller told his wife things looked foggy and when caller drives, caller can see further in the distance like black, kind of like smoke and if caller was wearing sunglasses. The caller used Xalatan eye drops and the caller switched to Latanoprost a couple of months ago or switched a year or so ago. The caller clarifies the caller was taking Xalatan a year ago and was not using Xalatan two weeks prior to receiving the Adult Pfizer Covid 19 Vaccine. The caller was taking Latanoprost when the caller received the Adult Pfizer Covid 19 Vaccine. The caller states Xalatan and Latanoprost are the same eye drop. The caller was taking the minimum dose of Latanoprost 0.1 of 0.5, really low. The caller does not know the units on the dose provided. No further information provided. No, additional vaccines administered on same date of the Pfizer suspect. No, the caller had never taken any vaccines but the Adult Pfizer Covid Vaccine, he was not sure about when caller was little. No, AE prior vaccinations.  No follow-up attempts are possible. No further information is expected.
FEVER, CHILLS, RIGORS, RED RASH AT SITE OF INJECTION
lips swollen; injection arm swollen; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lips swollen) and VACCINATION SITE SWELLING (injection arm swollen) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (takes medications for blood pressure). Concomitant products included PHENYTOIN SODIUM (DILANTIN [PHENYTOIN SODIUM]) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced LIP SWELLING (lips swollen) and VACCINATION SITE SWELLING (injection arm swollen). At the time of the report, LIP SWELLING (lips swollen) and VACCINATION SITE SWELLING (injection arm swollen) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product included blood pressure medication. Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt. c/o dizziness, alert, and verbally responsive. no change LOC mild lightheadedness.  :12:20 vitals- 77bpm, 19 cpm, 97%o2 106/60 BP 12:40 vitals - 79bpm, 18, cpm, 98%o2, 109/71 BP  #21 pt. went home
numbness and tingling in right side of face; numbness and tingling in right side of face; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s):   A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious), HYPOAESTHESIA (non-serious), outcome "recovered" and all described as "numbness and tingling in right side of face".  Additional information: On 02Sep2022, it was reported that a patient started treatment on unspecified date with Pfizer BioNTech COVID-19 Vaccine at dose 1 for an unknown indication. It was reported the patient had numbness and tingling in right side of face following first dose that lasted for months. No further follow-up is anticipated.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
NO ADVERSE REACTION EXPERIENCED. PRODUCT NO MIXED CORRECTLY. ONLY DILUENT ADMINISTERED. NO ANTIGEN COMPONENT ADMININSTERED. PATIENT CONTACTED AN TIME FOR REVACCINATION SCHEDULED.
This spontaneous report was received from a health professional referring to multiple patients of unknown age and gender. On an unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (Lot# K004483, expiration date 16-AUG-2015; K004487; expiration date 21-AUG-2015) dose and route of administration were not provided. No adverse effect reported. This service request was first opened on 30-JUN-2015, when a pharmacist called to reported a vaccine temperature excursion but any adverse event was reported at that time. However, this adverse event was reported on 11-AUG-2015, during a call back by this healthcare worker. This is one of several reports received from the same source. Additional information has been requested.
soreness in his hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 3, SINGLE; Lot number: Unknown), for COVID-19 immunization, reaction(s): "soreness in his hand"; Bnt162b2 (DOSE 2, SINGLE; Lot number: Unknown), for COVID-19 immunization, reaction(s): "soreness in his hand"; Bnt162b2 (DOSE 1, SINGLE; Lot number: Unknown), for COVID-19 immunization, reaction(s): "soreness in his hand". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "soreness in his hand".  Additional information: Reporter mentioned all of his 4 COVID 19 vaccines have been from Pfizer and with the previous ones he did not have any reaction at all, just soreness in his hand.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201229835 Same reporter/ patient, different event and dose.;
EXTREME BRUSING ON THE 10/6/20, THEN ON 11/1/20 RECEIVED THIS MESSAGE FROM PATIENT:  I mentioned that I had tendonitis in my right elbow from playing tennis. I am VERY dominant right sided and used my left arm a lot while letting my right elbow heal. My elbow has gotten much better but I now have a significant pain in the center of my left bicep and I have not been able to lift my arm without pain for over two weeks. I do not remember any one significant incident that created the pain. I have been wearing a sling but it hasn't helped a lot.
Patient experienced redness, swelling and skin was hot to touch. Extended to elbow and under arm.
Difficulty and pain with urinating. Multiple trips to bathroom to empty bladder with initial urination only producing a small dribble. Multiple trips to urinate during the night which rarely occurs before this incident. This started about 12 hours after vaccination.  Visit to urologist who made diagnosis of prostatitis. My prostate was very tender when examined. I felt this was likely vaccine related so I didn't use antibiotics. The symptoms abated over the course of 1 week and ended 8 days after onset. I am now back to normal.
12/29/21 presents to ED for "constipation and urinary incontinence". PMHx of "BPH, afib on eliquis, spinal stenosis"